Ibrutinib and idelalisib synergistically target BCR-controlled adhesion in MCL and CLL: a rationale for combination therapy

Martin F. M. de Rooij; Annemieke Kuil; Arnon P. Kater; Marie José Kersten; Steven T. Pals; Marcel Spaargaren

doi:https://doi.org/10.1182/blood-2014-12-619163

Ibrutinib and idelalisib synergistically target BCR-controlled adhesion in MCL and CLL: a rationale for combination therapy

Martin F. M. de Rooij, Annemieke Kuil, Arnon P. Kater, Marie José Kersten, Steven T. Pals, Marcel Spaargaren

Research output: Contribution to journal › Comment/Letter to the editor › Academic

80 Citations (Scopus)

Original language	English
Pages (from-to)	2306-2309
Journal	Blood
Volume	125
Issue number	14
DOIs	https://doi.org/10.1182/blood-2014-12-619163
Publication status	Published - 2015

Access to Document

https://doi.org/10.1182/blood-2014-12-619163

Cite this

@article{26b05a4a03674b68badbd25915875c50,

title = "Ibrutinib and idelalisib synergistically target BCR-controlled adhesion in MCL and CLL: a rationale for combination therapy",

author = "{de Rooij}, {Martin F. M.} and Annemieke Kuil and Kater, {Arnon P.} and Kersten, {Marie Jos{\'e}} and Pals, {Steven T.} and Marcel Spaargaren",

year = "2015",

doi = "https://doi.org/10.1182/blood-2014-12-619163",

language = "English",

volume = "125",

pages = "2306--2309",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "14",

}

TY - JOUR

T1 - Ibrutinib and idelalisib synergistically target BCR-controlled adhesion in MCL and CLL: a rationale for combination therapy

AU - de Rooij, Martin F. M.

AU - Kuil, Annemieke

AU - Kater, Arnon P.

AU - Kersten, Marie José

AU - Pals, Steven T.

AU - Spaargaren, Marcel

PY - 2015

Y1 - 2015

U2 - https://doi.org/10.1182/blood-2014-12-619163

DO - https://doi.org/10.1182/blood-2014-12-619163

M3 - Comment/Letter to the editor

C2 - 25838279

SN - 0006-4971

VL - 125

SP - 2306

EP - 2309

JO - Blood

JF - Blood

IS - 14

ER -